How can we improve communication of clinical study information and make the Informed Consent process more patient-friendly ?

Complicated words and sentences may be misunderstood and are very often unfamiliar to the patients. This led us to discuss how we could find the optimal solution for all parties involved in a clinical study: the patient, physician, and sponsor/CRO.

How To Bake A “Delicious” Pitch For Investors

Every Start-up knows the importance of a great pitch. Today we want to give you some advice on how to find out the essential ingredients to bake a delicious pitch which investors will enjoy every single bite. More importantly, leave them craving for more!

Major Milestone For Our Portfolio Company Inura Medical, Who Closes Their Pre-series A Financing Round

Inura Medical’s mission is to improve women’s health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Their first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB). 

Our portfolio company HexagonFab secures CHF 2.5m seed funding to speed discovery and production of the next-gen of biopharmaceuticals!

HexagonFab, a spin-out from the University of Cambridge, has developed a novel approach for drug discovery and production process monitoring called the Bolt. This innovative device is an analytical lab instrument that provides convenient and affordable access to molecular binding analytics.

Choose To Challenge

During the whole month of March, and in concrete today, you will find several discourses about empowering women and celebrating their social, economic, cultural, and political achievements. At HEMEX, we believe celebrating women is great, but we’re want to step forward and choose to challenge ourselves by smashing stereotypes and challenging gender bias.